YARAL Pharma Marks Its First Anniversary
PARSIPPANY, N.J.--(BUSINESS WIRE)--Yaral Pharma Inc., (Yaral Pharma) the United States generics subsidiary of IBSA (Institut Biochimique SA), today announced its expanding partnership with EVERSANA®, a leading provider of commercialization services to the global life sciences industry, as its key commercialization partner to support the expansion of its portfolio of pain and endocrinology products in the U.S. EVERSANA will provide a full range of services including, but not limited to, third-party logistics (3PL) and critical operations support to ensure best-in-class customer service for Yaral Pharma.